NHLBI Childhood Asthma Management Program (CAMP): What Have We Learned? CAMP began as a multicenter (8 clinical + 1 data coordinating center) clinical.

Slides:

Advertisements

Similar presentations

Repeat Chlamydia trachomatis: Rate and Predictors among Males Eileen F. Dunne M.D., M.P.H. JB Chapin, C Rietmeijer, CK Kent, J Ellen, C Gaydos, N Willard,

Advertisements

CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.

Infection as a treatable cause for asthma- Where do we go from here? David L Hahn, MD MS Workshop - September 2012.

AsthmaAsthma is a condition characterized by paroxysmal narrowing of the bronchial airways due to inflammation of the bronchi and contraction of the bronchial.

DACS 272 Neurologic deficits in the years following ART initiation among subjects in the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized.

Effects of Expanding Preventive Dental Care in Medical Offices for Young Children Covered by Medicaid Sally C. Stearns, PhD R. Gary Rozier, DDS Jeongyoung.

Childhood asthma Rod Addis, Vanessa Kerai. Overview Prevalence Prevalence Aetiology Aetiology Pathophysiology Pathophysiology Clinical features Clinical.

0 LCH UDS REPORT UDS Demographics Characteristics % Change Total Patients2,5652, % Male % Females1,6801, % 0.

Update on Acute Asthma Carlos Camargo, MD, DrPH Emergency Medicine, MGH Channing Laboratory, BWH Harvard Medical School

Asthma Leslie Boss (CDC) Carlos Camargo Denise Dougherty (AHRQ) Virginia Taggart (NHLBI) Sandra Wilson With Special Thanks to: Barbara DeVinney (NIH/OD)

Criner et al. NEJM 2014: 370; 23 Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD (STATCOPE) Presented by Ali Naqvi, MD.

05/12/04 Lung Health StudySlide 1 of 6 Lung Health Study Heavy Smokers Experienced a Greater Benefit in the Reduction of the Decline Rate of their Pulmonary.

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Asthma What is Asthma ? V1.0 1997 Merck & ..

Triage Nurse Initiation of Corticosteroids in Paediatric Asthma is Associated With Improved Emergency Department Efficiency Zemak et al Pediatrics Volume.

1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.

Inhaled corticosteroids in preschool asthmatic children

HIGH DOSES OF VITAMIN D TO REDUCE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL An Lehouck, PhD; Chantal Mathieu, MD, PhD;

British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.

The Long Term Multi-Center Extension of Dabigatran Treatment in Patients with Atrial Fibrillation (RELY-ABLE) study To reviewers and moderators: These.

Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)

La storia naturale dell’asma fernando maria de benedictis AOU “Ospedali Riuniti” - Ancona Ospedale Materno-Infantile di Alta Specializzazione “G. Salesi”

Interpretation Normal Spirometry Obstructive pattern Restrictive pattern Mixed pattern Small airway obstruction Non-specific ventilatory pattern Probably.

Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.

Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group,

Team Membership Dee Kaupie RCP, AE-C Sandy Swanson, RN Michael Wall, PharmD Kathleen Webster, MD Children's Asthma Care Core Measures Confidential: For.

PEDIATRIC ASTHMA Anna M. Suray, M.D Respiratory Update Weirton Medical Center March 17, 2008.

Food and Drug Administration Division of Pulmonary and Allergy Drug Products Pulmonary-Allergy Drugs Advisory Committee Meeting July 13, 2005 Safety of.

ORIGIN Outcome Reduction with an Initial Glargine Intervention (ORIGIN) Trial Overview Large international randomized controlled trial in patients with.

Asma na Infância Renato T. Stein, M.D. Pontifícia Universidade Católica Porto Alegre, Brazil.

FDA Advisory Committee May 15, 2003 Genentech Marketing Application STN / 0 Omalizumab Recombinant human anti-IgE for treatment of asthma Efficacy.

Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.

The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.

Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.

Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.

Asthma control test (ACT) scores and FeNO correlation

1 Otitis Media Results from the Kaiser Permanente Efficacy Trial Steven Black, MD, Henry Shinefield, MD and Bruce Fireman, MS Kaiser Permanente Vaccine.

A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.

Key Elements of a Primary Prevention Program. Percent of Preschool Children Exceeding Selected Blood Lead Levels, NHANES II - III Pirkle JL, et al. Environ.

The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.

INPULSIS® trial design and baseline characteristics

Asthma in Children Dr Rashmi Gaekwad ST3 7/11/12.

Long term effects of air pollution on health. Peter Burney. King’s College London.

SNDA Letrozole (Femara®) Indication: First-line therapy in post- menopausal women with advanced breast cancer. Prior approval: Second-line therapy.

Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.

Use of lung function tests in paediatric asthma care A nationwide registry study Grete Moth, MHSc, Ph.D Danish Paediatric Asthma Centre Aarhus University.

Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:

PHQ-9 Severity and Screening Tests Predictive of Remission Outcomes at Six Months Kurt B. Angstman, MS MD Associate Professor John M. Wilkinson Assistant.

LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,

Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.

Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.

Effect on growth of prolonged corticosteroid use for patients with Asthma in USTH Pediatric Out Patient Department.

Developmental Psychology Introduction to the Study of Development & A Look at Physical Development.

CHEST 2014; 145(4): 호흡기내과 R3 박세정. Cigarette smoking ㅡ the most important risk factor for COPD in the US. low value of FEV 1 : an independent predictor.

1 Once-daily indacaterol versus twice-daily salmeterol for COPD ; a placebo-controlled comparison R2 정명화 Eur Respir J 2011; 37: 273–279.

Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &

RI Asthma Control Program: Comprehensive Asthma Care

An effective COPD case finding strategy in Primary Care

Increased Exhaled Nitric Oxide and Risk of Loss of Control in Children Undergoing Clinical Asthma Remission D.V. Chang, J.E. Balinotti, C. Castro Simonelli,

Assessment and Monitoring Asthma and Clinical Action Plan

Research where it is most needed National Respiratory Strategy

BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM

Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult Bronchiectasis* Diana Bilton, MD;

Blood eosinophils as a biomarker in alpha 1 antitrypsin deficiency

The efficacy and safety of omalizumab in pediatric allergic asthma

Identificazione del sottogruppo di pazienti responsivi

Asthma Education for Families and HCPs

D94- COPD: EPIDEMIOLOGY AND THERAPY

Presentation transcript:

NHLBI Childhood Asthma Management Program (CAMP): What Have We Learned? CAMP began as a multicenter (8 clinical + 1 data coordinating center) clinical trial to determine the effect of antiinflammatory therapy on lung growth in children 5-12 years old (N=1046) with persistent mild to moderate asthma. It is now a longitudinal cohort follow-up study to determine the natural history of childhood asthma into adulthood. We currently are actively following 83% of the original cohort. Albuquerque Baltimore Boston Denver San Diego Seattle St Louis Toronto Johns Hopkins DCC

CAMP and CAMPCS Routine Care Randomize Treatment Phase Transition Phase 5 visits 3 visits per year 2 visits Discontinue Study Rx months 4 – 6 years 4 months Screening & Baseline Phase 1- 4 visits per year 13 years Follow- up Phases Enroll in CAMPCS, Rx directed by PCP per NAEPP Ned Bud Plbo 1994

Primary outcomes (123 peer-reviewed publications) Clinical Trial ICS improved bronchial hyper- responsiveness, symptoms, exacerbations, and healthcare utilization but not lung growth. ICS reduced linear growth but not BMD or HPA-axis, or cause cataracts or affect psychological development or neurocognitive functioning. Continuation Study Once discontinued all positive benefits lost (didn’t cure asthma). Lung growth exhibiting different patterns, unaffected by therapy. Linear growth still less in ICS group, bone-mineral accretion reduced by bursts of oral steroids but not ICS use. No increase in catarracts.

Age (yr) Reduced Growth Early Decline FEV 1 (% normal level at age 20) Normal Rapid Decline Rationale for Continuation of CAMP

Secondary outcomes (123 peer-reviewed publications) Genetics (60%) Beta-adrenergic response not related to Arg/Gly beta receptor polymorphisms. ICS response partially genetically determined, including growth suppression. Numerous papers on association of genes with asthma and various asthma characteristics. Others In utero smoke exposure impairs response to ICS. Low serum VitD levels associated with increase severe exacerbations. Correlations with HRCT structural findings and patterns of lung function decline. Post pubertal females have more severe bronchial responsiveness than males.